» Articles » PMID: 19840932

MiR-146a is Critical for Endotoxin-induced Tolerance: IMPLICATION IN INNATE IMMUNITY

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Oct 21
PMID 19840932
Citations 215
Authors
Affiliations
Soon will be listed here.
Abstract

The human toll-like receptor 4 (TLR4) pathway is activated in response to lipopolysaccharide (LPS), and subsequent signal transductions lead to the production of cytokines such as tumor necrosis factor-alpha (TNF-alpha) by innate immune cells. Defects in innate immune response may contribute to the overproduction of TNF-alpha leading to systemic inflammation and diseases. Thus, the innate immune response needs to be tightly regulated by elaborate mechanisms to control its onset and termination. LPS tolerance is a state of hyporesponsiveness to subsequent LPS challenge and is achieved by monocytic cells after prolonged exposure to LPS. In this report, kinetics of endotoxin-responsive microRNAs expression analysis revealed a unique pattern of gradual increase for miR-146a starting 4 h after LPS stimulation in THP-1 cells and continued up to 35-fold over 24 h. Conversely, TNF-alpha increased up to 4 h and then decreased gradually implicating a negative correlation with miR-146a progression. The characteristic up-regulation of miR-146a toward subsequent LPS challenge in THP-1 cells was studied. Strikingly, microRNA expression analysis during the tolerized state of THP-1 cells showed only miR-146a overexpression suggesting its important role in LPS tolerance. In addition, LPS tolerance was dependent on a LPS-priming dose and associated miR-146a up-regulation. LPS-tolerized cells were observed to regain responsiveness in TNF-alpha production 22 h after LPS removal correlating with a decrease in miR-146a level. Transfection of miR-146a into THP-1 cells mimicked LPS priming, whereas transfection of miR-146a inhibitor largely abolished LPS tolerance. Thus our studies demonstrated that miR-146a is critical for the in vitro monocytic cell-based endotoxin tolerance.

Citing Articles

Alterations in Small Non-coding MicroRNAs (miRNAs) and the Potential Role in the Development of Aseptic Loosening After Total Hip Replacement: Study Protocol for an Observational, Cross-Sectional Study.

Papagiannis S, Tatani I, Kyriakopoulos G, Kokkalis Z, Megas P, Stathopoulos C Cureus. 2024; 16(10):e72179.

PMID: 39583487 PMC: 11582946. DOI: 10.7759/cureus.72179.


Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.

Wang F, Mei X, Yang Y, Zhang H, Li Z, Zhu L Front Mol Biosci. 2024; 11:1388476.

PMID: 39318549 PMC: 11420011. DOI: 10.3389/fmolb.2024.1388476.


The complex effects of miR-146a in the pathogenesis of Alzheimer's disease.

Long Y, Liu J, Wang Y, Guo H, Cui G Neural Regen Res. 2024; 20(5):1309-1323.

PMID: 39075895 PMC: 11624861. DOI: 10.4103/NRR.NRR-D-23-01566.


Expression of miRNAs (146a and 155) in human peri-implant tissue affected by peri-implantitis: a case control study.

Hamed M, Abdulbaqi H BMC Oral Health. 2024; 24(1):856.

PMID: 39068455 PMC: 11283691. DOI: 10.1186/s12903-024-04579-x.


Integrative analysis of gene and microRNA expression profiles reveals candidate biomarkers and regulatory networks in psoriasis.

Chen L, Wang X, Liu C, Chen X, Li P, Qiu W Medicine (Baltimore). 2024; 103(29):e39002.

PMID: 39028999 PMC: 11398825. DOI: 10.1097/MD.0000000000039002.


References
1.
Blumenstein M, Kafferlein E, Kieper D, Petersmann I, Endres S, Flegel W . In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology. 1992; 75(2):264-8. PMC: 1384704. View

2.
Jacinto R, Hartung T, McCall C, Li L . Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol. 2002; 168(12):6136-41. DOI: 10.4049/jimmunol.168.12.6136. View

3.
Beeson P . TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT. J Exp Med. 2009; 86(1):29-38. PMC: 2135744. DOI: 10.1084/jem.86.1.29. View

4.
Chan E, Satoh M, Pauley K . Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need?. Arthritis Rheum. 2009; 60(4):912-5. PMC: 2792591. DOI: 10.1002/art.24421. View

5.
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M . Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000; 164(7):3476-9. DOI: 10.4049/jimmunol.164.7.3476. View